|
2001 Journal Article New perspectives on the role of aldosterone excess in cardiovascular diseaseStowasser, M (2001). New perspectives on the role of aldosterone excess in cardiovascular disease. Clinical And Experimental Pharmacology And Physiology, 28 (10), 783-791. doi: 10.1046/j.1440-1681.2001.03523.x |
|
2001 Journal Article Primary aldosteronism: Are we diagnosing and operating on too few patients?Gordon, RD, Stowasser, M and Rutherford, JC (2001). Primary aldosteronism: Are we diagnosing and operating on too few patients?. World Journal of Surgery, 25 (7), 941-947. doi: 10.1007/s00268-001-0033-4 |
|
2000 Journal Article Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?Collins, D., Coombes, J., Staatz, C. E., Stowasser, D. and Stowasser, M. (2000). Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?. Australian Journal of Hospital Pharmacy, 30 (2), 47-52. |
|
2000 Journal Article Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasiaBofinger, A., Hawley, C., Fisher, P., Daunt, N., Stowasser, M. and Gordon, Richard D. (2000). Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia. Journal of Human Hypertension, 14 (2), 91-94. |
|
2000 Journal Article Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasiaBofinger, A., Hawley, C., Fisher, P., Daunt, N., Stowasser, M. and Gordon, R. (2000). Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia. Journal of Human Hypertension, 14 (2), 91-94. doi: 10.1038/sj.jhh.1000935 |
|
2000 Journal Article Severity of hypertension in familial hyperaldosteronism type I: Relationship to gender and degree of biochemical disturbanceStowasser, M., Bachmann, A. W., Huggard, P. R., Rossetti, T. R. and Gordon, R. D. (2000). Severity of hypertension in familial hyperaldosteronism type I: Relationship to gender and degree of biochemical disturbance. The Journal of Clinical Endocrinology and Metabolism, 85 (6), 2160-2166. doi: 10.1210/jc.85.6.2160 |
|
2000 Journal Article Primary aldosteronism: learning from the study of familial varietiesStowasser, M and Gordon, RD (2000). Primary aldosteronism: learning from the study of familial varieties. Journal of Hypertension, 18 (9), 1165-1176. doi: 10.1097/00004872-200018090-00002 |
|
2000 Journal Article A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22)Lafferty, Antony R., Torpy, David J., Stowasser, Michael, Taymans, Susan E., Lin, Jing Ping, Huggard, Philip, Gordon, Richard D. and Stratakis, Constantine A. (2000). A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). Journal of Medical Genetics, 37 (11), 831-835. doi: 10.1136/jmg.37.11.831 |
|
2000 Journal Article Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?Stowasser, Danielle A., Staatz, Christine E., Stowasser, Michael, Coombes, Judith A. and Collins, David M. (2000). Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?. Australian Journal of Hospital Pharmacy, 30 (2), 47-53. doi: 10.1002/jppr200030247 |
|
2000 Conference Publication Angiotensin II (Angll) receptors in angll-response (Angll-R) and angll-unresponsive (Angll-U) aldosterone-producing adenoma (APA)Stowasser, M., Zhuo, J., Ohishi, M., Mendelsohn, F. and Gordon, R. D. (2000). Angiotensin II (Angll) receptors in angll-response (Angll-R) and angll-unresponsive (Angll-U) aldosterone-producing adenoma (APA). 18th Scientific Meeting of the Int. Society of Hypertension, Chicago, USA, 20-24 Aug 2000. Philadelphia, USA: Lippincott Williams & Wilkins. |
|
2000 Journal Article Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertensionStowasser, M, Bachmann, AW and Gordon, RD (2000). Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension. The Journal of Clinical Endocrinology and Metabolism, 85 (9), 3313-3318. doi: 10.1210/jc.85.9.3313 |
|
2000 Journal Article Treatment of familial hyperaldosteronism type I: Only partial suppression of adrenocorticotropin required to correct hypertensionStowasser, M., Bachmann, A. W., Huggard, P. R., Rossetti, T. R. and Gordon, R. D. (2000). Treatment of familial hyperaldosteronism type I: Only partial suppression of adrenocorticotropin required to correct hypertension. Journal of Clinical Endocrinology and Metabolism, 85 (9), 3313-3318. doi: 10.1210/jcem.85.9.6834 |
|
2000 Conference Publication Clinical, biochemical and radiological overlap between familial hyperaldosteronism types I and II: Importance of genetic testingStowasser, M, Taylor, W, Daunt, N, Slater, G, Rossetti, T and Gordon, R (2000). Clinical, biochemical and radiological overlap between familial hyperaldosteronism types I and II: Importance of genetic testing. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2000 Journal Article How common is adrenal-based mineralocortoid hypertension?Stowasser, M. (2000). How common is adrenal-based mineralocortoid hypertension?. Current Opinion in Endocrinology & Diabetes, 7 (3), 143-150. doi: 10.1097/00060793-200006000-00007 |
|
2000 Conference Publication Clinical, biomedical and radiological overlap between familial hyperaldosteronism type I and II: importance of genetic testingStowasser, M., Taylor, W., Daunt, N., Slater, G., Rossetti, T. and Gordon, R. D. (2000). Clinical, biomedical and radiological overlap between familial hyperaldosteronism type I and II: importance of genetic testing. Abstracts of the 18th Scientific Meeting of the Int. Society of Hypertension, Chicago, USA, 20-24 Aug 2000. Philadelphia, USA: Lippincott Williams & Wilkins. |
|
2000 Journal Article Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1pBenn, DE, Dwight, T, Richardson, AL, Delbridge, L, Bambach, CP, Stowasser, M, Gordon, RD, Marsh, DJ and Robinson, BG (2000). Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p. Cancer Research, 60 (24), 7048-7051. |
|
2000 Conference Publication Angiotensin II (AngII) receptors in AngII-responsive (AngII-R) and angII-unresponsive (AngII-U) aldosterone-producing adenoma (APA)Stowasser, M, Zhuo, J, Ohishi, M, Mendelsohn, F and Gordon, R (2000). Angiotensin II (AngII) receptors in AngII-responsive (AngII-R) and angII-unresponsive (AngII-U) aldosterone-producing adenoma (APA). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
1999 Journal Article Increased severity of multifocal renal arterial fibromuscular dysplasia in smokersBofinger, A. M., Hawley, C. M., Fisher, P. M., Daunt, N., Stowasser, M. and Gordon, Richard D. (1999). Increased severity of multifocal renal arterial fibromuscular dysplasia in smokers. Journal of Human Hypertension, 13 (8), 517-520. |
|
1999 Journal Article Expression of 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta-HSD-2) in the developing human adrenal gland and human adrenal cortical carcinoma and adenomaCoulter, Catherine L., Smith, Robin E., Stowasser, Michael, Sasano, Hironobu, Krozowski, Zygmunt S. and Gordon, Richard D. (1999). Expression of 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta-HSD-2) in the developing human adrenal gland and human adrenal cortical carcinoma and adenoma. Mollecular and Cellular endocrinology, 154 (1-2), 71-77. doi: 10.1016/S0303-7207(99)00077-5 |
|
1999 Journal Article Increased severity of multifocal renal arterial fibromuscular dysplasia in smokersBofinger, AM, Hawley, CM, Fisher, PM, Daunt, N, Stowasser, M and Gordon, RD (1999). Increased severity of multifocal renal arterial fibromuscular dysplasia in smokers. Journal of Human Hypertension, 13 (8), 517-520. doi: 10.1038/sj.jhh.1000873 |
